Literature DB >> 12890366

The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome.

Zhuo Li1, Xinhui Guo, Wa Hao, Yanning Wu, Yunxia Ji, Yanming Zhao, Fang Liu, Xianchun Xie.   

Abstract

OBJECTIVES: To observe the changes of serum interleukins (IL), T-lymphocyte subsets, and white blood cell (WBC) count in patients with severe acute respiratory syndrome (SARS), and to investigate the relationship between injured immune function, immune response and disturbed immune adjustment in SARS patients.
METHODS: The levels of serum IL-2, IL-10, IL-12 and T-lymphocyte subset counts were measured in 35 clinically diagnosed SARS patients by using enzyme linked immunosorbant assay (ELISA). The relationship between the measured results and WBC count was further analyzed.
RESULTS: The level of serum IL was increased to a great extent in the 35 SARS patients, and the levels of serum IL-2, IL-10 and IL-12 were 242.53 (92.69) pg/ml, 77.43 (63.37) pg/ml and 65.94 (43.21) pg/ml, respectively. The level of serum IL-2 increased markedly (P < 0.01). The peripheral blood CD(3)(+), CD(4)(+) and CD(8)(+) counts were lower than normal in 23 patients (67.7%), 26 patients (74.3%) and 15 patients (42.9%), respectively. The peripheral blood WBC counts were lower than 4.0 x 10(9)/L in 10 patients, and their CD(3)(+), CD(4)(+) and CD(8)(+) counts were 583.90 (315.58) x 10(6)/L, 272.00 (94.13) x 10(6)/L and 209.00 (72.21) x 10(6)/L, respectively. The peripheral blood WBC counts were (4.0 - 10.0) x 10(9)/L in 20 patients, and their CD(3)(+), CD(4)(+) and CD(8)(+) counts were 700.00 (502.96) x 10(6)/L, 347.00 (247.58) x 10(6)/L and 322.05 (228.47) x 10(6)/L, respectively. The peripheral blood WBC counts were higher than 10.0 x 10(9)/L in 5 patients, and their CD(3)(+), CD(4)(+) and CD(8)(+) counts were 1466.00 (630.86) x 10(6)/L, 783.00 (311.14) x 10(6)/L and 640.00 (294.40) x 10(6)/L, respectively. The decreased CD(3)(+), CD(4)(+) and CD(8)(+) counts were consistent with the decreased WBC counts. The level of IL in SARS patients was significantly higher than that in patients with chronic hepatitis B (P < 0.01).
CONCLUSIONS: The level of serum IL is closely related to cell immunity in SARS patients. The level of serum IL is increased evidently while CD(3)(+), CD(4)(+) and CD(8)(+) counts decrease. Both serum IL and CD are associated with injury of immune function, and thus they could be regarded as a monitoring index for judging the condition of SARS patients and prescribing immune therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890366

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  10 in total

1.  Cynomolgus macaque as an animal model for severe acute respiratory syndrome.

Authors:  James V Lawler; Timothy P Endy; Lisa E Hensley; Aura Garrison; Elizabeth A Fritz; May Lesar; Ralph S Baric; David A Kulesh; David A Norwood; Leonard P Wasieloski; Melanie P Ulrich; Tom R Slezak; Elizabeth Vitalis; John W Huggins; Peter B Jahrling; Jason Paragas
Journal:  PLoS Med       Date:  2006-04-18       Impact factor: 11.069

2.  ARDS in SARS: cytokine mediators and treatment implications.

Authors:  Manuel Salto-Tellez; Emily Tan; Bing Lim
Journal:  Cytokine       Date:  2005-01-21       Impact factor: 3.861

3.  Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome.

Authors:  Jia-Ling Huang; Jian Huang; Zhao-Hui Duan; Jing Wei; Jun Min; Xiao-Hong Luo; Jian-Guo Li; Wei-Ping Tan; Li-Zhi Wu; Ran-Yi Liu; Yan Li; Jing Shao; Bi-Jun Huang; Yi-Xin Zeng; Wenlin Huang
Journal:  Microbes Infect       Date:  2005-02-24       Impact factor: 2.700

4.  Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine.

Authors:  Ping Zhao; Jie Cao; Lan-Juan Zhao; Zhao-Lin Qin; Jin-Shan Ke; Wei Pan; Hao Ren; Jian-Guo Yu; Zhong-Tian Qi
Journal:  Virology       Date:  2005-01-05       Impact factor: 3.616

5.  Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.

Authors:  L He; Y Ding; Q Zhang; X Che; Y He; H Shen; H Wang; Z Li; L Zhao; J Geng; Y Deng; L Yang; J Li; J Cai; L Qiu; K Wen; X Xu; S Jiang
Journal:  J Pathol       Date:  2006-11       Impact factor: 7.996

6.  Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids.

Authors:  B M Jones; E S K Ma; J S M Peiris; P C Wong; J C M Ho; B Lam; K N Lai; K W T Tsang
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 7.  Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.

Authors:  Hanaa Ahmed-Hassan; Brianna Sisson; Rajni Kant Shukla; Yasasvi Wijewantha; Nicholas T Funderburg; Zihai Li; Don Hayes; Thorsten Demberg; Namal P M Liyanage
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

8.  Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway.

Authors:  Wei Wang; Linbai Ye; Li Ye; Baozong Li; Bo Gao; Yingchun Zeng; Lingbao Kong; Xiaonan Fang; Hong Zheng; Zhenghui Wu; Yinglong She
Journal:  Virus Res       Date:  2007-05-25       Impact factor: 3.303

Review 9. 

Authors:  Julien Malarewicz; Romain Kirchacker; Djillali Annane
Journal:  Prat Anesth Reanim       Date:  2008-01-03

Review 10.  Immune Profiling of COVID-19 in Correlation with SARS and MERS.

Authors:  Bariaa A Khalil; Sarra B Shakartalla; Swati Goel; Bushra Madkhana; Rabih Halwani; Azzam A Maghazachi; Habiba AlSafar; Basem Al-Omari; Mohammad T Al Bataineh
Journal:  Viruses       Date:  2022-01-17       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.